UBS Group’s Churchill Capital Corp VII Class A Common Stock CVII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50
Closed -$525 10242
2023
Q4
$525 Sell
50
-86
-63% -$901 ﹤0.01% 8614
2023
Q3
$1.42K Buy
+136
New +$1.42K ﹤0.01% 7948
2023
Q1
Sell
-2,561
Closed -$25.5K 10730
2022
Q4
$25.5K Sell
2,561
-24,789
-91% -$246K ﹤0.01% 7402
2022
Q3
$269K Sell
27,350
-6,608
-19% -$64.8K ﹤0.01% 4851
2022
Q2
$332K Buy
33,958
+3,366
+11% +$32.9K ﹤0.01% 4570
2022
Q1
$300K Buy
30,592
+2,823
+10% +$27.5K ﹤0.01% 5066
2021
Q4
$273K Buy
+27,769
New +$272K ﹤0.01% 5433

Other funds holding CVII

UBS Group's CVII Position: Q1 2024 in Review

UBS Group sold out of Churchill Capital Corp VII Class A Common Stock (CVII) in Q1 2024, closing a stake of 50 shares — an estimated $525 sold.

UBS Group first reported a position in CVII in Q4 2021 and held it in 7 quarters. The position peaked at $332K in Q2 2022. 51 funds tracked by Wall St. Rank hold CVII as of Q1 2024.

  • UBS Group reported no remaining Churchill Capital Corp VII Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • UBS Group sold 50 Churchill Capital Corp VII Class A Common Stock shares in Q1 2024, an estimated $525.
  • UBS Group first reported a position in Churchill Capital Corp VII Class A Common Stock in Q4 2021 and held it in 7 quarters.
  • UBS Group's Churchill Capital Corp VII Class A Common Stock position peaked at $332K in Q2 2022.
  • 51 funds tracked by Wall St. Rank held Churchill Capital Corp VII Class A Common Stock as of Q1 2024.

Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.